GLOBAL PRICING POLICIES AND COST-EFFECTIVENESS OF TRASTUZUMAB IN LATIN AMERICA

被引：0
|
作者：
Giffin, Robert B. [1 ]
机构：
[1] Medtronic, Minneapolis, MN 55432 USA
来源：
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE | 2015年 / 31卷 / 1-2期
关键词：
Compilation and indexing terms; Copyright 2024 Elsevier Inc;
D O I：
10.1017/S026646231500029X
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Low HER2 Expression
    Huang, Xiaoting
    Lin, Dong
    Lin, Shen
    Luo, Shaohong
    Huang, Xiaojia
    Deng, Yujie
    Weng, Xiuhua
    Huang, Pinfang
    CLINICAL BREAST CANCER, 2023, 23 (05) : 508 - 518
  • [42] THE IMPACT OF FINNISH PHARMACEUTICAL PRICING SCHEME IN COST-EFFECTIVENESS ANALYSES
    Hallinen, T.
    Soini, E. J.
    VALUE IN HEALTH, 2010, 13 (07) : A249 - A249
  • [43] Pricing life: The controversial role of cost-effectiveness in health care
    Williams, A
    HEALTH ECONOMICS, 2001, 10 (01) : 87 - 88
  • [44] Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer
    Dai, Wei Fang
    Beca, Jaclyn M.
    Nagamuthu, Chenthila
    Liu, Ning
    de Oliveira, Claire
    Earle, Craig C.
    Trudeau, Maureen
    Chan, Kelvin K. W.
    JAMA ONCOLOGY, 2022, 8 (04) : 597 - 606
  • [45] Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium
    Neyt, Mattias
    Huybrechts, Michel
    Hulstaert, Frank
    Vrijens, France
    Ramaekers, Dirk
    HEALTH POLICY, 2008, 87 (02) : 146 - 159
  • [46] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
  • [47] Global Pressures, National Policies, and Labor Rights in Latin America
    Katrina Burgess
    Studies in Comparative International Development, 2010, 45 : 198 - 224
  • [48] Global Pressures, National Policies, and Labor Rights in Latin America
    Burgess, Katrina
    STUDIES IN COMPARATIVE INTERNATIONAL DEVELOPMENT, 2010, 45 (02) : 198 - 224
  • [49] COST-EFFECTIVENESS OF PERTUZUMAB PLUS TRASTUZUMAB VS TRASTUZUMAB IN NEOADJUVANT SETTING BASED ON THE NEOSPHERE TRIAL IN TURKEY
    Erdogan-Ciftci, E.
    Yanik, L.
    Saka, O.
    Thuresson, P. O.
    VALUE IN HEALTH, 2019, 22 : S483 - S484
  • [50] COST-EFFECTIVENESS OF SAXAGLIPTIN TREATMENT IN THREE LATIN AMERICAN COUNTRIES
    Elgart, J. F.
    Caporale, J. E.
    Aiello, E. C.
    Waschbusch, M.
    Jotimliansky, L.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2011, 14 (07) : A547 - A547
12345